Mitochondrial TSPO Promotes Hepatocellular Carcinoma Progression through Ferroptosis Inhibition and Immune Evasion
Advanced Science · 2023-05 · 10 (15)
DOI: 10.1002/advs.202206669 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 30.03.2023. Verfasst von Deguo Zhang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangz…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Ferroptosis, Liver Neoplasms. Die Arbeit wurde bisher 112-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Health Commission of Zhejiang Province, National Natural Science Foundation of China, Huadong MedicineJoint Funds of the Zhejiang Provincial Natural Science Foundation of China.
Abstract (Originalsprache)
Hepatocellular carcinoma (HCC) is one of the most common malignancies with poor prognosis, and novel treatment strategies are urgently needed. Mitochondria are key regulators of cellular homeostasis and potential targets for tumor therapy. Here, the role of mitochondrial translocator protein (TSPO) in the regulation of ferroptosis and antitumor immunity is investigated and the potential therapeutic implications for HCC are assessed. TSPO is highly expressed in HCC and associated with poor prognosis. Gain‐ and loss‐of‐function experiments present that TSPO promotes HCC cell growth, migration, and invasion in vitro and in vivo. In addition, TSPO inhibits ferroptosis in HCC cells via enhancing the Nrf2‐dependent antioxidant defense system. Mechanistically, TSPO directly interacts with P62 and interferes with autophagy, leading to the accumulation of P62. The P62 accumulation competes with KEAP1, preventing it from targeting Nrf2 for proteasomal degradation. Furthermore, TSPO promotes HCC immune escape by upregulating PD‐L1 expression through Nrf2‐mediated transcription. Notably, TSPO inhibitor PK11195 combines with anti‐PD‐1 antibody showing a synergistic anti‐tumor effect in a mouse model. Overall, the results demonstrated that mitochondrial TSPO promotes HCC progression by inhibiting ferroptosis and antitumor immunity. Targeting TSPO can be a promising new strategy for HCC treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang Province, 310003, China.
- NHC Key Laboratory of Combined Multi-organ Transplantation, Hangzhou, Zhejiang Province, 310003, China.
- Key Laboratory of the Diagnosis and Treatment of Organ Transplantation, Research Unit of Collaborative Diagnosis and Treatment For Hepatobiliary and Pancreatic Cancer, Chinese Academy of Medical Sciences (2019RU019), Ha…
- Key Laboratory of Organ Transplantation, Research Center for Diagnosis and Treatment of Hepatobiliary Diseases, Hangzhou, Zhejiang Province, 310003, China.
ORCID-Profile: Deguo Zhang, Jian Wu
Förderung
- Health Commission of Zhejiang Province
- National Natural Science Foundation of China
- Huadong MedicineJoint Funds of the Zhejiang Provincial Natural Science Foundation of China
- Research Unit Project of Chinese Academy of Medical Sciences
Zitieren
APA
Zhang, D., Man, D., Lu, J., Jiang, Y., Ding, B., Su, R., Tong, R., Chen, J., Yang, B., Zheng, S., Chen, D., & Wu, J. (2023). Mitochondrial TSPO Promotes Hepatocellular Carcinoma Progression through Ferroptosis Inhibition and Immune Evasion. Advanced Science, 10(15). https://doi.org/10.1002/advs.202206669
Vancouver
Zhang D, Man D, Lu J, Jiang Y, Ding B, Su R, et al. Mitochondrial TSPO Promotes Hepatocellular Carcinoma Progression through Ferroptosis Inhibition and Immune Evasion. Advanced Science. 2023;10(15). doi:10.1002/advs.202206669
BibTeX
@article{Zhang2023,
author = {Zhang, Deguo and Man, Da and Lu, Jiahua and Jiang, Yifan and Ding, Bo and Su, Rong and Tong, Rongliang and Chen, Junru and Yang, Beng and Zheng, Shusen and Chen, Diyu and Wu, Jian},
title = {Mitochondrial TSPO Promotes Hepatocellular Carcinoma Progression through Ferroptosis Inhibition and Immune Evasion},
journal = {Advanced Science},
year = {2023},
volume = {10},
number = {15},
doi = {10.1002/advs.202206669}
}
EUVIMED